LoginSignup
Formycon logo

Formycon

Stock
Stock
ISIN: DE000A1EWVY8
Ticker: FYB
DE000A1EWVY8
FYB

Price

Price

Frequently asked questions

What is Formycon's market capitalization?

The market capitalization of Formycon is $870.94M. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.

What is Formycon's Price-to-Earnings (P/E) ratio?

The Price-to-Earnings (P/E) ratio (TTM) for Formycon is 11.76. This ratio helps investors assess whether a stock is overvalued or undervalued compared to its earnings.

What is the Earnings Per Share (EPS) for Formycon?

Formycon's Earnings Per Share (EPS) over the trailing twelve months (TTM) is $4.192. EPS indicates the company's profitability on a per-share basis.

What are the analyst ratings and target price for Formycon's stock?

Currently, 11 analysts cover Formycon's stock, with a consensus target price of $94.35. Analyst ratings provide insights into the stock's expected performance.

What is Formycon's revenue over the trailing twelve months?

Over the trailing twelve months, Formycon reported a revenue of $63.71M.

What is the EBITDA for Formycon?

Formycon's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is -$23.73M. EBITDA measures the company's overall financial performance.

What is the free cash flow of Formycon?

Formycon has a free cash flow of -$61.79M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.

What is the 5-year beta of Formycon's stock?

The 5-year beta for Formycon is 0.63. A beta value indicates the stock's volatility relative to the market; a beta greater than 1 means higher volatility.

How many employees does Formycon have, and what sector and industry does it belong to?

Formycon employs approximately 239 people. It operates in the Health Care sector, specifically within the Biotechnology & Drugs industry.

What is the free float of Formycon's shares?

The free float of Formycon is 11.19M. Free float refers to the number of shares available for public trading, excluding restricted shares.

Financials

Market Cap

 $870.94M

5Y beta

 0.63

EPS (TTM)

 $4.192

Free Float

 11.19M

P/E ratio (TTM)

 11.76

Revenue (TTM)

 $63.71M

EBITDA (TTM)

 -$23.73M

Free Cashflow (TTM)

 -$61.79M

Pricing

1D span
$48.69$50.47
52W span
$40.12$73.76

Analyst Ratings

The price target is $94.35 and the stock is covered by 11 analysts.

Buy

10

Hold

1

Sell

0

Information

Formycon AG is a Germany-based company engaged in providing biosimilar drugs and formulations. Its business activities are focused on the development and marketing of biopharmaceuticals that are similar to existing drugs, for which the patent protection is expiring. The Company focuses on treatments in the area of ophthalmology, immunology and other chronic diseases, covering all steps of biosimilar development process, from early-stage analysis of the originator drug to the preclinical and clinical testing phases, as well as the preparation of dossiers for marketing approval. Its biosimilar product pipeline consists of four candidates in pre-clinical and clinical testing phases, including FYB201, a biosimilar candidate for Lucentis; FYB202, a biosimilar candidate for Stelara; FYB203, a biosimilar candidate for Eylea, and FYB205.

239

Biotechnology & Drugs

Health Care

Identifier

ISIN

DE000A1EWVY8

Primary Ticker

FYB

Knockouts

Join the conversation
Sign upLogin